Skip to content

Lung ultrasound (LUS) as a tool to determine the clinical course in COVID-19 patients

Lung ultrasound (LUS) as a tool to determine the clinical course in COVID-19 patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON26808
Enrollment
20
Registered
2020-03-31
Start date
2020-03-15
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV2 infection

Interventions

Lung Ultrasound

Sponsors

Radboudumc
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age (=18 years) Proven(PCR) or suspected (based on clinical signs and imaging) COVID-19 infection- Referral or admission for internal, emergency or respiratory medicine- Certified sonographerpresent

Exclusion criteria

Exclusion criteria: -Pre-existing pulmonary disease or heart failure -Absence of COVID infection

Design outcomes

Primary

MeasureTime frame
Patients will receive regular care as indicated by the treating physician. LUS is performed immediately in the Emergency Department or after admissionto the hospital. SARS-CoV-2 PCR testing will be performed along with standard laboratory testing and other microbiological tests to detect pathogens that cause respiratory tract infection.CT-scan during admission is only performed if this is clinically indicated or protocol during COVID outbreak.

Secondary

MeasureTime frame
•CT report by radiologist(CORADSscore)• Laboratory results including flocked swab and COVID-19 PCR.• Laboratory investigations: as determined by the local department, but at least: oCRP, d-dimer, troponin, ferritin, LDH, lymphopenia, NT-proBNP• LUS results data for 12locations with scoring systemof LUS•Final diagnosis at discharge • Clinical outcome:discharge, death, IC admission• Hospitalization days and ICU admission days, number of days on mechanical ventilation

Contacts

Public ContactFrank Bosch

Radboudumc

frank.bosch@radboudumc.nl+31243619880

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)